|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/08 | (2006.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 7/02 | (2006.01) |
| (11) | Number of the document | 4181872 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21739730.6 |
| Date of filing the European patent application | 2021-07-14 | |
| (97) | Date of publication of the European application | 2023-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-26 |
| (46) | Date of publication of the claims translation | 2026-02-10 |
| (86) | Number | PCT/EP2021/069579 |
| Date | 2021-07-14 |
| (87) | Number | WO 2022/013276 |
| Date | 2022-01-20 |
| (30) | Number | Date | Country code |
| PCT/EP2020/069976 | 2020-07-15 | WO |
| (72) |
BUCHMANN, Stephan , CH
FRAICHARD, Amandine , CH
HERRMANN, Charlyse , CH
LIENHART, Céline , CH
VON RAUMER, Markus , CH
WERK, Tobias , CH
|
| (73) |
Viatris Asia Pacific Pte. Ltd. ,
2 Shenton Way, No. 18-01
SGX Centre 1, Singapore 068864,
SG
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Vandeninė farmacinė kompozicija, apimanti P2Y12 receptoriaus antagonistą |
| AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING A P2Y12 RECEPTOR ANTAGONIST |